Ann: Preliminary Final Report, page-47

imo the product development is their current priority focus.

No doubt whilst this is in progress a marketing program is being formulated with particular emphasis on the distribution plan. Permetrex gives them a distinct POD and no doubt they are assessing the best strategy to utilise and on sell this system. Discussions with interested parties with a view to collaborations will imo be forthcoming as the release of product is imminent.

Shareholders are always anxious/fearful, that is human nature and goes with the territory of any investment. Botanix is sticking to their plan and for me personally I am happy to ride my investment well into 2018 before paying specific attention to the share price.

BOT has not put a foot wrong with knocking over their milestones and I expect this progress to continue.